The Scientist - Home

The microbiome-testing company made misleading claims about its prospects and about its business strategy, which allegedly relied on fooling doctors into ordering unnecessary tests, according to the US government.

The vaccine was 79 percent effective at blocking symptomatic infections, according to data from a Phase 3 trial in the US, Chile, and Peru. A US safety oversight board says the data might be incomplete.

The physiological demands of that long neck get support from a gene involved in strengthening bones and blood vessels, researchers find after inserting the sequence in mice.

Researchers have collected hundreds of COVID-19–related diabetes case reports since August of last year, in hopes of teasing apart the complex links between the two diseases.

Two of the implanted valves lasted a full year as the animals matured into adult sheep, demonstrating that it might be possible to treat children with valve replacements that grow along with them.

The embryos completed one-third of their total gestation outside of a uterus.

ASAPbio has developed resources for preprint servers, institutions, scientists, and journalists to promote the responsible reporting of research in the media.

Authors of a new review urge researchers to consider how the chromosomal sex of a cell affects experiments in research on neurodegeneration.

In mice, epigenetic marks made on histones during infancy influence depression-like behavior during adulthood. A drug that reverses the genomic tags appears to undo the damage.

The agreement comes two years after the university system cut ties with the publisher after failing to come to an agreement.

Two new papers describe the generation of so-called blastoids, which could avoid the use of embryonic cells and make studying early human development much more accessible.

Electrical storms, rather than meteorites as scientists had previously thought, could have unlocked phosphorus necessary for the development of ancient life, according to a new study.